Results 221 to 230 of about 2,211,934 (230)

Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications

Reviews in Endocrine & Metabolic Disorders, 2020
G. Fanciulli, R. Ruggeri, E. Grossrubatscher, F. L. Calzo, T. D. Wood, A. Faggiano, A. Isidori, A. Colao, on behalf of Nike   +8 more
semanticscholar   +1 more source

Carcinoid Syndrome: Updates and Review of Current Therapy

Current Treatment Options in Oncology, 2019
K. Oleinikov, Shani Avniel-Polak, D. Gross, S. Grozinsky-Glasberg   +3 more
semanticscholar   +1 more source

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.

The Lancet Oncology, 2017
D. Halperin, Chan Shen, A. Dasari, Ying Xu, Y. Chu, Shouhao Zhou, Y. Shih, James C. Yao   +7 more
semanticscholar   +1 more source

Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea

Drugs, 2018
K. Lyseng-Williamson
semanticscholar   +1 more source

Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea

Cancer Chemotherapy and Pharmacology, 2017
Muhammad Masab, M. Saif
semanticscholar   +1 more source

Carcinoid Syndrome

Encyclopedia of Endocrine Diseases, 2019
M. Tsoli, G. Kaltsas
semanticscholar   +1 more source

Carcinoid transformation of presacral dermoid cyst in patient with currarino syndrome: a case report

British Journal of Neurosurgery, 2019
F. Colombo, P. Janous, N. Buxton
semanticscholar   +1 more source

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study

American Journal of Surgical Pathology, 2018
M. Mengoli, G. Rossi, A. Cavazza, R. Franco, F. Marino, M. Migaldi, L. Gnetti, E. Silini, L. Ampollini, M. Tiseo, F. Lococo, L. Fournel, P. Spagnolo, V. Cottin, T. Colby   +14 more
semanticscholar   +1 more source

Cognitive Impairment Associated With Carcinoid Syndrome

Annals of Surgery, 2014
Janice L. Pasieka, R. S. Longman, Anthony J. Chambers, O. Rorstad, Kathy Rach-Longman, E. Dixon   +5 more
semanticscholar   +1 more source

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

The Lancet, 2011
M. Pavel, J. Hainsworth, E. Baudin, M. Peeters, D. Hörsch, R. Winkler, J. Klimovsky, D. Lebwohl, V. Jehl, E. Wolin, K. Öberg, E. Cutsem, James C. Yao   +12 more
semanticscholar   +1 more source